These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17203011)

  • 21. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
    Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prepulse inhibition and habituation of acoustic startle response in male MDMA ('ecstasy') users, cannabis users, and healthy controls.
    Quednow BB; Kühn KU; Hoenig K; Maier W; Wagner M
    Neuropsychopharmacology; 2004 May; 29(5):982-90. PubMed ID: 14970829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Executive function in abstinent MDMA ('ecstasy') users.
    Zakzanis KK; Young DA
    Med Sci Monit; 2001; 7(6):1292-8. PubMed ID: 11687745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of learning, memory, and executive function in new MDMA users.
    Wagner D; Becker B; Koester P; Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2013 Jan; 108(1):136-45. PubMed ID: 22831704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
    Parrott AC; Lasky J
    Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review.
    Montoya AG; Sorrentino R; Lukas SE; Price BH
    Harv Rev Psychiatry; 2002; 10(4):212-20. PubMed ID: 12119307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
    McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
    Bhattachary S; Powell JH
    Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL; Shear PK; Corcoran K
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Morgan MJ; Impallomeni LC; Pirona A; Rogers RD
    Neuropsychopharmacology; 2006 Jul; 31(7):1562-73. PubMed ID: 16292322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self reported sleep quality and cognitive performance in ecstasy users.
    Montgomery C; Fisk JE; Wareing M; Murphy P
    Hum Psychopharmacol; 2007 Dec; 22(8):537-48. PubMed ID: 17960556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study.
    Daumann J; Fimm B; Willmes K; Thron A; Gouzoulis-Mayfrank E
    Brain Res Cogn Brain Res; 2003 May; 16(3):479-87. PubMed ID: 12706227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.
    McCann UD; Ridenour A; Shaham Y; Ricaurte GA
    Neuropsychopharmacology; 1994 Apr; 10(2):129-38. PubMed ID: 7517677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.
    Casco C; Forcella M; Beretta G; Grieco A; Campana G
    Addict Biol; 2005 Jun; 10(2):187-95. PubMed ID: 16191672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neuropsychology of ecstasy (MDMA) use: a quantitative review.
    Zakzanis KK; Campbell Z; Jovanovski D
    Hum Psychopharmacol; 2007 Oct; 22(7):427-35. PubMed ID: 17896346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memory performance in abstinent 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.
    Groth-Marnat G; Howchar H; Marsh A
    Percept Mot Skills; 2007 Feb; 104(1):43-55. PubMed ID: 17450963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge.
    Taffe MA; Davis SA; Yuan J; Schroeder R; Hatzidimitriou G; Parsons LH; Ricaurte GA; Gold LH
    Neuropsychopharmacology; 2002 Dec; 27(6):993-1005. PubMed ID: 12464456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
    Morgan MJ
    Neuropsychopharmacology; 1998 Oct; 19(4):252-64. PubMed ID: 9718589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verbal working memory deficits in current and previous users of MDMA.
    Wareing M; Fisk JE; Murphy P; Montgomery C
    Hum Psychopharmacol; 2004 Jun; 19(4):225-34. PubMed ID: 15181650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.